Research programme: therapeutics - VLife Sciences TechnologiesAlternative Names: VB498; VB747
Latest Information Update: 30 Nov 2005
At a glance
- Originator VLife Sciences Technologies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase Unknown Cancer
Most Recent Events
- 30 Nov 2005 Investigation in Cancer in India (unspecified route)